AAAAAA

   
Results: 1-23 |
Results: 23
UNTITLED
Authors: CAMPION M
Citation: M. Campion, UNTITLED, Journal of cataract and refractive surgery, 24(3), 1998, pp. 293-293
AN OPEN-LABELED TOLERABILITY STUDY OF INTERFERON BETA-1A IN COMBINATION WITH STEROIDS AND PENTOXYFYLLINE IN PATIENTS WITH MODERATE TO SEVERE MULTIPLE-SCLEROSIS
Authors: SIMONIAN N GOODMAN A GUARNACCIA J JACOBS L SIRDOFSKY M BLANCHARD N CAMPION M COHEN J
Citation: N. Simonian et al., AN OPEN-LABELED TOLERABILITY STUDY OF INTERFERON BETA-1A IN COMBINATION WITH STEROIDS AND PENTOXYFYLLINE IN PATIENTS WITH MODERATE TO SEVERE MULTIPLE-SCLEROSIS, Annals of neurology, 44(3), 1998, pp. 246-246
IMAGING AND MULTIPLE-SCLEROSIS - REPLY
Authors: SIMON JH JACOBS LD CAMPION M
Citation: Jh. Simon et al., IMAGING AND MULTIPLE-SCLEROSIS - REPLY, Annals of neurology, 44(3), 1998, pp. 424-425
MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: SIMON JH JACOBS LD CAMPION M WENDE K SIMONIAN N COOKFAIR DL RUDICK RA HERNDON RM RICHERT JR SALAZAR AM ALAM JJ FISCHER JS GOODKIN DE GRANGER CV LAJAUNIE M MARTENSDAVIDSON AL MEYER MJ SHEEDER J CHOI K SCHERZINGER AL BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEINSTOCKGUTTMAN B WHITHAM RH
Citation: Jh. Simon et al., MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 43(1), 1998, pp. 79-87
INCIDENCE AND SIGNIFICANCE OF NEUTRALIZING ANTIBODIES TO INTERFERON BETA-1A IN MULTIPLE-SCLEROSIS
Authors: RUDICK RA SIMONIAN NA ALAM JA CAMPION M SCARAMUCCI JO JONES W COATS ME GOODKIN DE WEINSTOCKGUTTMAN B HERNDON RM MASS MK RICHERT JR SALAZAR AM MUNSCHAUER FE COOKFAIR DL SIMON JH JACOBS LD
Citation: Ra. Rudick et al., INCIDENCE AND SIGNIFICANCE OF NEUTRALIZING ANTIBODIES TO INTERFERON BETA-1A IN MULTIPLE-SCLEROSIS, Neurology, 50(5), 1998, pp. 1266-1272
2-STEP ASSAY SYSTEM FOR DETERMINATION OF ANTIBODIES TO INTERFERON-BETA
Authors: ALSABBAGH AM SIMONIAN N CAMPION M LERNER M SARNELLI T EMERZIAN B JONES W
Citation: Am. Alsabbagh et al., 2-STEP ASSAY SYSTEM FOR DETERMINATION OF ANTIBODIES TO INTERFERON-BETA, Neurology, 50(4), 1998, pp. 1076-1076
A LONGITUDINAL-STUDY OF BRAIN ATROPHY IN RELAPSING MS
Authors: SIMON JH JACOBS LD CAMPION M RUDICK RA
Citation: Jh. Simon et al., A LONGITUDINAL-STUDY OF BRAIN ATROPHY IN RELAPSING MS, Neurology, 50(4), 1998, pp. 17006-17006
COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 RECOMBINANT HUMAN INTERFERON BETA-1A (IFN-BETA-1A) PRODUCTS ADMINISTERED INTRAMUSCULARLY IN HEALTHY MALE AND FEMALE VOLUNTEERS
Authors: ALAM J GOELZ S RIOUX P SCARAMUCCI J JONES W MCALLISTER A CAMPION M ROGGE M
Citation: J. Alam et al., COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 RECOMBINANT HUMAN INTERFERON BETA-1A (IFN-BETA-1A) PRODUCTS ADMINISTERED INTRAMUSCULARLY IN HEALTHY MALE AND FEMALE VOLUNTEERS, Pharmaceutical research, 14(4), 1997, pp. 546-549
ONGOING EFFICACY AND SAFETY ANALYSIS OF INTERFERON-BETA-1A (AVONEX) IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: HERNDON RM COATS M GOODKIN D MASS M RICHERT J RUDICK RA WEINSTOCKGUTTMAN B SIMONIAN NA CAMPION M SCARAMOCCI J ALAM JJ JACOBS LD
Citation: Rm. Herndon et al., ONGOING EFFICACY AND SAFETY ANALYSIS OF INTERFERON-BETA-1A (AVONEX) IN PATIENTS WITH MULTIPLE-SCLEROSIS, Annals of neurology, 42(6), 1997, pp. 6-6
SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS
Authors: RUDICK RA JONES W ALAM J SIMONIAN N CAMPION M JACOBS L HERNDON R RICHERT J SALAZAR A COOKFAIR D SIMON J COATS M GOODKIN D MASS M
Citation: Ra. Rudick et al., SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 5003-5003
THEORY AND PRACTICE OF DISTANCE EDUCATION - HOLMBERG,B
Authors: CAMPION M
Citation: M. Campion, THEORY AND PRACTICE OF DISTANCE EDUCATION - HOLMBERG,B, Innovations in education and training international, 33(1), 1996, pp. 79-80
INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS
Authors: JACOBS LD COOKFAIR DL RUDICK RA HERNDON RM RICHERT JR SALAZAR AM FISCHER JS GOODKIN DE GRANGER CV SIMON JH ALAM JJ BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEINSTOCKGUTTMAN B WHITMAN RH BAIRD WC FILLMORE M BONA LM COLONRUIZ ME NADINE BS DONOVAN A BENNETT S KIEFFER YM UMHAUER MA MILLER CE KILIC AK SARGENT EL SCHACHTER M SHUCARD DW WEIDER V CATALANO BA CERVI JM CZEKAY C FARRELL JL FILIPPINI JS MATYAS RC MICHIENZI KE ITO M OMALLEY JA ZIELEZNY MA BRUN JM DAVIDSON AL GREEN LA OREILLY KM SHELTON JA WENDE KE BARILLA DY BOYLE SL PERKINS KK PERRYMAN JE STIEBELING BG KONECSNI JF ROSS JS CHOI KS GUSTAFSON CJ QUANDT BJ SCHERZINGER AL GRIFFITH DA HARRIS JM LEZAK MD MIMICA I SAUNDERS JA COIT WE FORCE CR GILMORE FJ HARRIS LB JONES MM KAUFFMAN JA MARBERGER KE MCBRIDE JW MILLER LL WRIGHT GK BROOKS JA BROWN HR GRAVES ME SCHMIDT JA MOTHENA JW GRAFMAN JH KENWORTHY MK MORTON MM BROWN DM BROWN DC LEVY LM BORDEN EC RANSOHOFF RM VILCEK JT MCCARTHYKIRBY K CAMPION M
Citation: Ld. Jacobs et al., INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 39(3), 1996, pp. 285-294
ECONOMIC-IMPACT OF RA AND OA - INDIRECT AND NONMEDICAL COSTS
Authors: GABRIEL S CROWSON C CAMPION M OFALLON WM
Citation: S. Gabriel et al., ECONOMIC-IMPACT OF RA AND OA - INDIRECT AND NONMEDICAL COSTS, Arthritis and rheumatism, 39(9), 1996, pp. 268-268
ECONOMIC-IMPACT OF RA-AND-OA - DIRECT MEDICAL COSTS
Authors: GABRIEL S CROWSON C CAMPION M OFALLON WM
Citation: S. Gabriel et al., ECONOMIC-IMPACT OF RA-AND-OA - DIRECT MEDICAL COSTS, Arthritis and rheumatism, 39(9), 1996, pp. 1735-1735
PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RINEHART J MARGOLIN KA TRIOZZI P HERSH E CAMPION M RESTA D LEVITT D
Citation: J. Rinehart et al., PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Clinical cancer research, 1(10), 1995, pp. 1139-1144
PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER
Authors: LAZARUS HM WINTON EF WILLIAMS SF GRINBLATT D CAMPION M COOPER BW GUNN H MANFREDA S ISAACS RE
Citation: Hm. Lazarus et al., PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER, Bone marrow transplantation, 15(6), 1995, pp. 935-942
POSSIBLE ROLE FOR HUMAN PAPILLOMAVIRUS-16 IN SQUAMOUS-CELL CARCINOMA OF THE FINGER
Authors: SANCHEZLANIER M TRIPLETT C CAMPION M
Citation: M. Sanchezlanier et al., POSSIBLE ROLE FOR HUMAN PAPILLOMAVIRUS-16 IN SQUAMOUS-CELL CARCINOMA OF THE FINGER, Journal of medical virology, 44(4), 1994, pp. 369-378
SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I II MULTICENTER STUDY/
Authors: FAY JW LAZARUS H HERZIG R SAEZ R STEVENS DA COLLINS RH PINEIRO LA COOPER BW DICESARE J CAMPION M FELSER JM HERZIG G BERNSTEIN SH
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I II MULTICENTER STUDY/, Blood, 84(7), 1994, pp. 2151-2157
PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: NEMUNAITIS J APPELBAUM FR SINGER JW LILLEBY K WOLFF S GREER JP BIERMAN P RESTA D CAMPION M LEVITT D ZEIGLER Z ROSENFELD C SHADDUCK RK BUCKNER CD
Citation: J. Nemunaitis et al., PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 82(11), 1993, pp. 3273-3278
PHASE-1 STUDY OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6, ESCHERICHIA-COLI) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN PATIENTS WITHPOOR-PROGNOSIS BREAST-CANCER
Authors: LAZARUS HM WINTON EF WILLIAMS SF GRINBLATT D CAMPION M MANFREDA S COOPER BW ISAACS RE
Citation: Hm. Lazarus et al., PHASE-1 STUDY OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6, ESCHERICHIA-COLI) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN PATIENTS WITHPOOR-PROGNOSIS BREAST-CANCER, Blood, 82(10), 1993, pp. 10000173-10000173
SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 (RHIL-3) AND RHGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN UPDATE OF THE PHASE-I II TRIAL/
Authors: FAY JW FELSER J LAZARUS HM HERZIG R SAEZ R STEVENS D COLLINS RH PINERO L COOPER B HERZIG GP CAMPION M DICESARE J BERNSTEIN SH
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 (RHIL-3) AND RHGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN UPDATE OF THE PHASE-I II TRIAL/, Blood, 82(10), 1993, pp. 10000287-10000287
PHASE-I II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) FOLLOWING IFOSPHAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA (NSCLC)/
Authors: CRAWFORD J FIGLIN R CHANG A HAMM J WASSERHEIT C LEE M CAMPION M MANFREDA S ISAACS R
Citation: J. Crawford et al., PHASE-I II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) FOLLOWING IFOSPHAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA (NSCLC)/, Blood, 82(10), 1993, pp. 10000367-10000367
STIMULATION OF THROMBOPOIESIS BY RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6) PRE-CHEMOTHERAPY AND POSTCHEMOTHERAPY IN PREVIOUSLY UNTREATED SARCOMA PATIENTS WITH NORMAL HEMATOPOIESIS
Authors: DEMETRI GD BUKOWSKI RM SAMUELS B GORDON M ANTMAN K MERICA EA SAMUEL S CAMPION M LEVITT D ISAACS R
Citation: Gd. Demetri et al., STIMULATION OF THROMBOPOIESIS BY RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6) PRE-CHEMOTHERAPY AND POSTCHEMOTHERAPY IN PREVIOUSLY UNTREATED SARCOMA PATIENTS WITH NORMAL HEMATOPOIESIS, Blood, 82(10), 1993, pp. 10000367-10000367
Risultati: 1-23 |